BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6400311)

  • 1. Improvement of production and control methods of live dysentery vaccine Vadizen (Shigella flexneri 2a T32-Istrati).
    Meitert T; Ciudin L; Pencu E; Tonciu M; Gheorghe G
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):357-67. PubMed ID: 6400311
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of dysentery vaccinations by live vaccine Vadizen (Sh. flexneri 2a T32-Istrati) in children collectivities in GL.
    Brebenel G; Barabas E; Delcea D; Meitert T; Pencu E; Ciudin L
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):299-304. PubMed ID: 6400303
    [No Abstract]   [Full Text] [Related]  

  • 3. Live dysentery vaccine "Vadizen" (T32-Istrati) immunogenicity against Shigella-like challenge in animals.
    Ciudin L; Meitert T; Pencu E; Gheorghe G; Tonciu M; Mihai I; Manase R
    Arch Roum Pathol Exp Microbiol; 1986; 45(3-4):247-56. PubMed ID: 3300598
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoprophylaxis against bacillary dysentery by dysentery live vaccine Vadizen (Shigella flexneri T32-Istrati) in children collectivities in SV County.
    Bogus L; Ianopol L; Dascălu C; Bende B; Iliescu C; Carliuc V; Meitert T; Pencu E; Ciudin L; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):291-8. PubMed ID: 6400302
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati).
    Meitert T; Pencu E; Ciudin L; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):251-78. PubMed ID: 6400299
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoprophylactic effect of dysentery vaccination by live dysentery vaccine Vadizen (Sh. flexneri T32-Istrati) in children and adult collectivities in BT County.
    Cîmpeanu S; Harasim T; Popovici S; Popa T; Meitert T; Pencu E; Ciudin L; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):305-12. PubMed ID: 6400304
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of morbidity due to bacillary dysentery by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in BH County.
    Pop C; Cernea L; Ciortea A; Ianossy L; Kallay T; Lugoş A; Meitert T; Ciudin L; Pencu E
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):351-6. PubMed ID: 6400310
    [No Abstract]   [Full Text] [Related]  

  • 8. Antidysentery vaccination by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in PH County.
    Cuteanu I; Malamen G; Vlad A; Meitert T; Ciudin L; Pencu E; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):313-21. PubMed ID: 6400305
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigations concerning the immunoprophylactic effect of the antidysentery vaccination by live vaccine Vadizen (Sh. flexneri T32-Istrati) in children.
    Dragomir I; Iancu V; Călţun M; Raicu M; Meitert T; Pencu E; Ciudin L
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):323-9. PubMed ID: 6400306
    [No Abstract]   [Full Text] [Related]  

  • 10. Prophylaxis of bacillary dysentery by liver vaccine Vadizen (Sh. flexneri T32-Istrati) in children collectivities in IS County.
    Oană C; Buzdugan T; Constantiniu S; Cismaru M; Alexandru D; Dunea C; Funiac A; Radu M; Grumăzescu C; Meitert T
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):331-5. PubMed ID: 6400307
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of humoral antibodies against Shigella flexneri 2a T32 (Istrati) by ELISA.
    Meitert T; Carlsson B; Pencu E; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):279-84. PubMed ID: 6400300
    [No Abstract]   [Full Text] [Related]  

  • 12. Virulence phenotype and genetic characteristics of the T32-ISTRATI Shigella flexneri 2a vaccine strain.
    Venkatesan M; Fernandez-Prada C; Buysse JM; Formal SB; Hale TL
    Vaccine; 1991 May; 9(5):358-63. PubMed ID: 1872021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The optimization of the technology for culturing vaccinal strains of Shigella flexneri].
    Basnak'ian IA; Miriasova LV; Sokolova TV; Ian'kova MM; Kalina NG; Elkina SI; Sergeev VV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (5):6-10. PubMed ID: 8067146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cellular and humoral immune response after administration to the guinea pig of Shigella flexneri 2a T32--Istrati vaccinal strain by different routes.
    Meitert T; Radu I; Ciudin L; Pencu E; Tonciu M
    Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):267-76. PubMed ID: 395927
    [No Abstract]   [Full Text] [Related]  

  • 15. [Construction of a typhoid-dysentery bivalent strain with typhoid ty21a and dysentery T32-Istrati strains].
    Chen QY; Jiang LJ; Kong DC; Wang BR
    Wei Sheng Wu Xue Bao; 1987 Dec; 27(4):362-8. PubMed ID: 3329424
    [No Abstract]   [Full Text] [Related]  

  • 16. Study on the effect of oral immunization of T32-Istrati strain against bacillary dysentery in field trials.
    Bingrui W
    Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):285-9. PubMed ID: 6400301
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity and characterization of WRSF2G11: a second generation live attenuated Shigella flexneri 2a vaccine strain.
    Ranallo RT; Thakkar S; Chen Q; Venkatesan MM
    Vaccine; 2007 Mar; 25(12):2269-78. PubMed ID: 17229494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Shigella vaccine safety and efficacy in an intranasally challenged mouse model.
    Mallett CP; VanDeVerg L; Collins HH; Hale TL
    Vaccine; 1993; 11(2):190-6. PubMed ID: 8438617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
    Rui X; Xu Y; Wan H; Su G; Huang C
    Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection.
    Phalipon A; Tanguy M; Grandjean C; Guerreiro C; Bélot F; Cohen D; Sansonetti PJ; Mulard LA
    J Immunol; 2009 Feb; 182(4):2241-7. PubMed ID: 19201878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.